000			01547 a2200457 4500
005			20250514155855.0
264		0	_c20031224
008			200312s 0 0 eng d
022			_a1464-2662
024	7		_a10.1046/j.1468-1293.2003.00168.x _2doi
040			_aNLM _beng _cNLM
100	1		_aClements, Mark
245	0	0	_aEstimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data. _h[electronic resource]
260			_bHIV medicine _cOct 2003
300			_a332-7 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aAnti-Retroviral Agents _xtherapeutic use
650	0	4	_aAustralia _xepidemiology
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCohort Studies
650	0	4	_aConfounding Factors, Epidemiologic
650	0	4	_aEurope _xepidemiology
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Seropositivity _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aRegression Analysis
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aLaw, Matthew
700	1		_aPedersen, Court
700	1		_aKaldor, John
773	0		_tHIV medicine _gvol. 4 _gno. 4 _gp. 332-7
856	4	0	_uhttps://doi.org/10.1046/j.1468-1293.2003.00168.x _zAvailable from publisher's website
999			_c14285409 _d14285409